Trials / Completed
CompletedNCT05447507
Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation
Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation During Regional Block
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the sedation efficacy of dexmedetomidine and remimazolam for intraoperative sedation during regional block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | 0.075 mg/kg Remimazolam bolus infusion for 1 min, then 0.5\~1.0 mg/kg/h continuous infusion |
| DRUG | Dexmedetomidine | 1 mcg/kg Dexmedetomidine infusion for 10 min, then 0.2\~0.7 mcg/kg/h continuous infusion |
Timeline
- Start date
- 2022-07-08
- Primary completion
- 2022-10-26
- Completion
- 2022-10-26
- First posted
- 2022-07-07
- Last updated
- 2022-11-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05447507. Inclusion in this directory is not an endorsement.